Global Access Diagnostics (GADx)
- Home
- Companies
- Global Access Diagnostics (GADx)
- Products
- Model EPIDEMICS - Rapid Diagnostics
Model EPIDEMICS - Rapid Diagnostics
Rapid Diagnostics for epidemics are critical for the surveillance, containment and elimination of epidemics in the absence of a vaccine programme. Since 2018, Global Access Diagnostics (GADx) has increased its focus on epidemics and neglected diseases, with support from the Gates Foundation, the Wellcome Trust, the UK government, and the Foundation for Innovative New Diagnostics (FIND). By detecting outbreaks early, in settings where laboratory capacity is limited, we can support more precise and responsive public health measures and immunisation campaigns.